Jeffrey N. Weitzel

1990–2025 年に発表

123
論文数
22,841
被引用数
78
h 指数
116
i10 指数

被引用数

Jeffrey N. Weitzel の年別被引用数1992 年: 被引用 1 件1993 年: 被引用 1 件1996 年: 被引用 1 件1997 年: 被引用 1 件1999 年: 被引用 5 件2000 年: 被引用 7 件2001 年: 被引用 5 件2002 年: 被引用 5 件2003 年: 被引用 7 件2004 年: 被引用 9 件2005 年: 被引用 15 件2006 年: 被引用 22 件2007 年: 被引用 35 件2008 年: 被引用 41 件2009 年: 被引用 63 件2010 年: 被引用 156 件2011 年: 被引用 240 件2012 年: 被引用 187 件2013 年: 被引用 221 件2014 年: 被引用 254 件2015 年: 被引用 232 件2016 年: 被引用 258 件2017 年: 被引用 280 件2018 年: 被引用 237 件2019 年: 被引用 812 件2020 年: 被引用 844 件2021 年: 被引用 815 件2022 年: 被引用 635 件2023 年: 被引用 422 件2024 年: 被引用 781 件2025 年: 被引用 296 件2026 年: 被引用 7 件1994〜1995 年は被引用が無いため表示していません1998 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,651 件、この内訳の 26.4%イギリス: 引用元論文 780 件、この内訳の 7.8%中国: 引用元論文 542 件、この内訳の 5.4%カナダ: 引用元論文 496 件、この内訳の 4.9%イタリア: 引用元論文 457 件、この内訳の 4.5%ドイツ: 引用元論文 394 件、この内訳の 3.9%オーストラリア: 引用元論文 392 件、この内訳の 3.9%フランス: 引用元論文 337 件、この内訳の 3.4%スペイン: 引用元論文 301 件、この内訳の 3%オランダ: 引用元論文 294 件、この内訳の 2.9%スウェーデン: 引用元論文 171 件、この内訳の 1.7%ポーランド: 引用元論文 164 件、この内訳の 1.6%
0%26.4%その他 30.6%

分野

  • Biochemistry, Genetics and Molecular Biology51.5%
  • Medicine44.3%
  • Computer Science0.7%
  • Health Professions0.5%
  • Immunology and Microbiology0.5%
  • Agricultural and Biological Sciences0.4%
  • その他2.1%

トピック

  • BRCA gene mutations in cancer12.6%
  • PARP inhibition in cancer therapy6.6%
  • Cancer Genomics and Diagnostics6.5%
  • DNA Repair Mechanisms5%
  • Genetic factors in colorectal cancer4.8%
  • Breast Cancer Treatment Studies3.2%
  • その他61.3%

共著者

全論文

検索で開く
  1. Cancer health disparities in racial/ethnic minorities in the United States

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Laura Fejerman - British Journal of Cancer 2020 被引用: 906

  2. Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kristen M. Shannon, Rebecca Shatsky, Kala Visvanathan, Jeffrey N. Weitzel, Myra Wick, Kari B. Wisinski, Matthew B. Yurgelun, Susan Darlow, Mary A. Dwyer - Journal of the National Comprehensive Cancer Network 2021 被引用: 1,115

  3. A Population-Based Study of Genes Previously Implicated in Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Loı̈c Le Marchand, Sara Lindströem, Tricia Lindstrom, Huiyan Ma, Susan L. Neuhausen, Polly A. Newcomb, Katie M. O’Brien, Janet E. Olson, Irene M. Ong, Tuya Pal, Julie R. Palmer, Alpa V. Patel, Sonya Reid, Lynn Rosenberg, Dale P. Sandler, Christopher J. Scott, Rulla M. Tamimi, Jack A. Taylor, Amy Trentham‐Dietz, Celine M. Vachon, Clarice R. Weinberg, Song Yao, Argyrios Ziogas, Jeffrey N. Weitzel, David E. Goldgar, Susan M. Domchek, Katherine L. Nathanson, Peter Kraft, Eric C. Polley, Fergus J. Couch - New England Journal of Medicine 2021 被引用: 866

  4. Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial

    著者: , , , , , , , , , , , , , , - The Lancet 2010 被引用: 2,283

  5. Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer

    著者: , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2019 被引用: 308

  6. Circulating tumor DNA as an early cancer detection tool

    著者: , , , , , , , , , , - Pharmacology & Therapeutics 2019 被引用: 246

  7. Contralateral Breast Cancer Risk Among Carriers of Germline Pathogenic Variants inATM,BRCA1,BRCA2,CHEK2, andPALB2

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Julie R. Palmer, Susan M. Domchek, Jeffrey N. Weitzel, Katherine L. Nathanson, Peter Kraft, Fergus J. Couch - Journal of Clinical Oncology 2023 被引用: 173

  8. Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

    著者: , , , , , , , , , , , , , , - The Lancet 2010 被引用: 1,636

  9. Breast-Cancer Risk in Families with Mutations in PALB2

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bruce Poppe, Kathleen Claes, Drakoulis Yannoukakos, Patrick Concannon, Jonine L. Bernstein, Paul A. James, Douglas F. Easton, David E. Goldgar, John L. Hopper, Nazneen Rahman, Paolo Peterlongo, Heli Nevanlinna, Mary‐Claire King, Fergus J. Couch, Melissa C. Southey, Robert Winqvist, William D. Foulkes, Marc Tischkowitz - New England Journal of Medicine 2014 被引用: 855

  10. Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jacqueline Powers, Raoul S. Concepcion, Daniel W. Lin, Richard C. Wender, James Ryan Mark, Anthony J. Costello, Arthur L. Burnett, Oliver Sartor, William B. Isaacs, Jianfeng Xu, Jeffrey N. Weitzel, Gerald L. Andriole, Himisha Beltran, Alberto Briganti, Lindsey Byrne, Anne Calvaresi, Thenappan Chandrasekar, David Y.T. Chen, Robert B. Den, Albert Dobi, E. David Crawford, James A. Eastham, Scott E. Eggener, Matthew L. Freedman, Marc B. Garnick, Patrick T. Gomella, Nathan Handley, Mark Hurwitz, Joseph K. Izes, R. Jeffrey Karnes, Costas D. Lallas, Lucia R. Languino, Stacy Loeb, Ana María López, Kevin R. Loughlin, Grace Lu‐Yao, S. Bruce Malkowicz, Mark Mann, Patrick Mille, Martin Miner, Todd M. Morgan, José Moreno, Lorelei A. Mucci, Ronald E. Myers, Sarah M. Nielsen, Brock O’Neil, Wayne H. Pinover, Peter A. Pinto, Wendy Poage, Ganesh V. Raj, Timothy R. Rebbeck, Charles J. Ryan, Howard M. Sandler, Matthew J. Schiewer, Emily Scott, Brittany M. Szymaniak, William Tester, Edouard J. Trabulsi, Neha Vapiwala, Evan Y. Yu, Charnita Zeigler‐Johnson, Leonard G. Gomella - Journal of Clinical Oncology 2020 被引用: 279

  11. Analysis of the Li-Fraumeni Spectrum Based on an International Germline TP53 Variant Data Set

    著者: , , , , , , , , , , , - JAMA Oncology 2021 被引用: 146

  12. Association of Type and Location ofBRCA1andBRCA2Mutations With Risk of Breast and Ovarian Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kunle Odunsi, Simon A. Gayther, Susan M. Domchek, Banu Arun, Karen H. Lu, Gillian Mitchell, Beth Y. Karlan, Christine Walsh, Jenny Lester, Andrew K. Godwin, Harsh B. Pathak, Eric A. Ross, Mary B. Daly, Alice S. Whittemore, Esther M. John, Alexander Miron, Mary Beth Terry, Wendy K. Chung, David E. Goldgar, Saundra S. Buys, Ramūnas Janavičius, Laima Tihomirova, Nadine Tung, Cecilia M. Dorfling, Elizabeth J. van Rensburg, Linda Steele, Susan L. Neuhausen, Yuan Chun Ding, Bent Ejlertsen, Anne‐Marie Gerdes, Thomas van Overeem Hansen, Teresa Ramón y Cajal, Ana Osório, Javier Benı́tez, Javier Godino, María‐Isabel Tejada, M. Durán, Jeffrey N. Weitzel, Kristie Bobolis, Sharon Sand, Annette Campbell Fontaine, Antonella Savarese, Barbara Pasini, Bernard Peissel, Bernardo Bonanni, Daniela Zaffaroni, Francesca Vignolo-Lutati, Giulietta Scuvera, Giuseppe Giannini, Loris Bernard, Maurizio Genuardi, Paolo Radice, Riccardo Dolcetti, Siranoush Manoukian, Valeria Pensotti, Viviana Gismondi, Drakoulis Yannoukakos, Florentia Fostira, Judy E. Garber, Diana Torres, Muhammad Usman Rashid, Ute Hamann, Susan Peock, Debra Frost, Radka Platte, D. Gareth Evans, Rosalind A. Eeles, Rosemarie Davidson, Diana Eccles, Trevor Cole ほか 158 名 - JAMA 2015 被引用: 509

  13. Association of a Polygenic Risk Score With Breast Cancer Among Women Carriers of High- and Moderate-Risk Breast Cancer Genes

    著者: , , , , , , , , , , , , , - JAMA Network Open 2020 被引用: 137

  14. NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kari B. Wisinski, Mary A. Dwyer, Susan Darlow - Journal of the National Comprehensive Cancer Network 2020 被引用: 507

  15. Breast Cancer Screening Strategies for Women With ATM, CHEK2, and PALB2 Pathogenic Variants

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Leslie Berstein, Kimberly A. Bertrand, Elizabeth S. Burnside, Brian D. Carter, A. Heather Eliassen, Mia M. Gaudet, Christopher Haiman, James M. Hodge, David J. Hunter, Eric J. Jacobs, Esther M. John, Charles Kooperberg, James V. Lacey, Loı̈c Le Marchand, Sara Lindström, Huiyan Ma, Elena Martínez, Susan L. Neuhausen, Polly A. Newcomb, Katie M. O’Brien, Janet E. Olson, Irene M. Ong, Tuya Pal, Julie R. Palmer, Alpa V. Patel, Sonya Reid, Lynn Rosenberg, Dale P. Sandler, Rulla M. Tamimi, Jack A. Taylor, Lauren R. Teras, Celine M. Vachon, Clarice R. Weinberg, Siddhartha Yadav, Song Yao, Argyrios Ziogas, Jeffrey N. Weitzel, David E. Goldgar - JAMA Oncology 2022 被引用: 87

  16. Beyond Li Fraumeni Syndrome: Clinical Characteristics of Families With p53 Germline Mutations

    著者: , , , , , , , , , , - Journal of Clinical Oncology 2009 被引用: 606

  17. International trends in the uptake of cancer risk reduction strategies in women with a BRCA1 or BRCA2 mutation

    著者: , , , , , , , , , , , , , , , , , - British Journal of Cancer 2019 被引用: 179

  18. Germline Pathogenic Variants in Cancer Predisposition Genes Among Women With Invasive Lobular Carcinoma of the Breast

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hoda Anton-Culver, Christine B. Ambrosone, Rachid Karam, Elizabeth Chao, Amal Yussuf, Tina Pesaran, Jill S. Dolinsky, Steven N. Hart, Holly LaDuca, Eric C. Polley, Susan M. Domchek, Fergus J. Couch - Journal of Clinical Oncology 2021 被引用: 50

  19. Baseline Surveillance in Li-Fraumeni Syndrome Using Whole-Body Magnetic Resonance Imaging

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mark E. Robson, Michael F. Walsh, Lorenzo Manelli, Anita Villani, David M. Thomas, Sharon A. Savage - JAMA Oncology 2017 被引用: 194

  20. Risk of Breast Cancer Among Carriers of Pathogenic Variants in Breast Cancer Predisposition Genes Varies by Polygenic Risk Score

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jack A. Taylor, Lauren R. Teras, Amy Trentham‐Dietz, Celine M. Vachon, Clarice R. Weinberg, Song Yao, Jeffrey N. Weitzel, David E. Goldgar, Susan M. Domchek, Katherine L. Nathanson, Fergus J. Couch, Peter Kraft - Journal of Clinical Oncology 2021 被引用: 94

  21. NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of the National Comprehensive Cancer Network 2016 被引用: 661

  22. Genetics, genomics, and cancer risk assessment

    著者: , , , , - CA A Cancer Journal for Clinicians 2011 被引用: 251

  23. Somatic TP53 variants frequently confound germ-line testing results

    著者: , , , , , , , , , , , , , , , , - Genetics in Medicine 2017 被引用: 125

  24. Identification of Incidental Germline Mutations in Patients With Advanced Solid Tumors Who Underwent Cell-Free Circulating Tumor DNA Sequencing

    著者: , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2018 被引用: 114